Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News on Pharma

Cheaper private Covid jabs may end up as costly as pricier ones, say experts

Exclusive: Multi-dose vials could push up charge per patient, with experts warning cost could widen inequalities

The Guardian - UK

NPPA revises ceiling prices of over 800 scheduled drug formulations from April 1

Cost of antibiotics and painkillers have registered a marginal hike in cost starting with the drug price regulator National Pharmaceutical Pricing Authority’s latest notification

The Hindu

Drug Company's Libel Lawsuit Against Scientists Dismissed

From yesterday's decision by Judge Gregory Woods (S.D.N.Y.) in Cassava Sciences, Inc. v. Bredt: Cassava Sciences, Inc. ("Cassava") is a biotechnology company that is conducting clinical trials for an Alzheimer's drug called simufilam. Following the second phase of the simufilam clinical trials, multiple short sellers, most of them scientists, published…

Reason

From analysis to the latest developments in health,
read the most diverse news in one place.

Nearly 1,000 pharmacies in England closed since 2017, with poorer areas more affected

Exclusive: Millions more GP appointments potentially created as a result of closures

The Guardian - UK

New List Out On Medicare Part B Drugs Eligible for Rebates

Some Medicare beneficiaries may pay lower coinsurance rates from April 1 to June 30 for the drugs, HHS says.

Kiplinger

19th Century law versus bodily autonomy

Abortion opponents are citing the Comstock Act to stop "abortion pill trafficking." Experts say that's nonsense

Salon

'Everywhere I look private companies are more valuable': Biotech firm C4X becomes latest to quit London stock market

Biotech firm C4X today became the latest business to abandon the London stock market after is said its future growth would be better secured through private investment.

Evening Standard

Read news from The Economist, FT, and more,
with one subscription

US Supreme Court hears arguments in abortion pill case

U.S. Supreme Court justices on Tuesday did not appear ready to limit access to the abortion pill mifepristone, in a case that could have far-reaching implications for millions of American women and for scores of drugs regulated by the Food and Drug Administration.

France 24

Abortion pill ruling could be "catastrophic" for new drug development

"It would be a catastrophic event."

Axios

Supreme Court To Decide High-Stakes Abortion Pill Case

The Supreme Court's upcoming decision on mifepristone's approval process could have significant implications for reproductive rights and healthcare access ...

Top News

U.S. Supreme Court takes up Texas case challenging abortion pill access

A majority of Supreme Court justices seemed open to keeping mifepristone, a common abortion-inducing drug, on the market despite a Texas ruling revoking its FDA approval.

The Texas Tribune

SCOTUS abortion pill hearing puts FDA discretion on trial

A ruling against expanded mifepristone access could set a precedent for courts to substitute their own conclusions for agency decisions.

Axios

How the abortion pill case at the supreme court could undo the FDA

The mifepristone case is viewed with trepidation by the medical industry and could have enormous consequences for drug regulation

The Guardian - US

US-style executive pay packets in UK would ‘risk higher inequality’

Leading social scientists issue warning after call by business leaders and London Stock Exchange

The Guardian - UK

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - US

How rightwing groups used junk science to get an abortion case before the US supreme court

Anti-abortion researchers ‘exaggerate’ and ‘obfuscate’ in their scientific papers – but by the time they’re published, it’s too late

The Hindu

Electoral Bonds data | Firms from Telangana, A.P. loosened purse strings for multiple political parties

Companies in Hyderabad purchased electoral bonds for various political parties, revealing significant donations and recipients in Telangana and Andhra Pradesh.

StockNews.com

3 Pharma Gems Poised for Breakthroughs

The pharmaceutical industry is rapidly expanding, fueled by continued R&D efforts leading to the discovery of new drugs and therapies, biotechnology innovations, and growing medical needs. Thus, let’s take a look at pharma gems Pacira BioSciences (PCRX), Calliditas Therapeutics (CALT), and Astellas Pharma (ALPMY) poised for breakthroughs. Read more….

Salon

Why some abortion patients go to the ER

A small portion of patients do visit ERs after an abortion, but it's not because mifepristone is unsafe

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

3 Pharma Stocks Outperforming the Competition

The growing demand for innovative drugs, the use of advanced technologies, and growing global healthcare needs boost the pharmaceutical industry’s long-term growth prospects. Therefore, fundamentally strong pharma stocks Viatris (VTRS), Wave Life Sciences (WVE), and MEI Pharma (MEIP) might be ideal additions to your portfolio. Read on.

StockNews.com

4 Cutting-Edge Pharma Stocks for Portfolio Diversification

The pharmaceutical industry is expected to grow rapidly due to increasing healthcare demand, technological advancements, and rising demand for innovative drugs. Therefore, for portfolio diversification, investors could consider buying fundamentally strong pharmaceutical stocks such as Bayer (BAYRY), Procaps Group (PROC), ACADIA Pharmaceuticals (ACAD), and Zoetis (ZTS). Read more.

The Hindu

Many pharma companies that bought electoral bonds faced regulatory actions

Top pharmaceutical companies purchased electoral bonds amidst regulatory scrutiny, including Hetero, MSN, Divi's, Intas, Lupin, Mankind, Micro Labs, and Natco.

StockNews.com

3 Pharma Stocks Fueling Investor Enthusiasm

The pharmaceutical industry is expected to expand rapidly due to growing global healthcare needs and advancements in technology. Therefore, fundamentally strong pharma stocks Merck (MRK), AbbVie (ABBV), and GSK plc (GSK) might be ideal additions to your portfolio. Read on.

StockNews.com

Top 3 Pharma Innovators to Watch Closely

The pharmaceutical industry is experiencing considerable growth, driven by rising healthcare needs, continuous advances in drug discovery & discovery, and M&A activity. So, investors could keep a close eye on top pharma stocks Amneal Pharmaceuticals (AMRX), Collegium Pharmaceutical (COLL), and Sanofi (SNY) for potential gains. Keep reading….

StockNews.com

Biotech Investors: Should You Buy, Hold, or Sell Moderna (MRNA) and Arrowhead Pharmaceuticals (ARWR)?

Despite facing several challenges, the biotech sector thrives due to growing demand for effective treatments, consistent innovations, and a sustained demand for high-quality drugs and therapies. Let's assess whether one should Buy, Hold, or Sell biotech stocks Moderna (MRNA) and Arrowhead Pharmaceuticals (ARWR). Keep reading.

StockNews.com

3 B-Rated Biotech Stocks to Boost Your Bottom Line

The biotech industry’s growth prospects look promising due to innovative drugs and therapies, government initiatives, and technological advancements. Therefore, investors could consider buying fundamentally strong biotech stocks BioMarin Pharmaceutical (BMRN), Illumina (ILMN), and Harmony Biosciences (HRMY). These stocks are B-rated (Buy) in our proprietary rating system. Read on.

1 … 33 34 35 36

People

Ketanji Brown Jackson

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Bharatiya Janata Party

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.